AVENTIS PHARMACEUTICAL INC has a total of 18 patent applications. Its first patent ever was published in 1996. It filed its patents most often in China, Hong Kong and Mexico. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CELGENE AVILOMICS RES INC, ASTELLAS PHARMA INC and NOVEXEL.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | Hong Kong | 3 | |
#3 | Mexico | 2 | |
#4 | Australia | 1 | |
#5 | Israel | 1 | |
#6 | Panama | 1 | |
#7 | United States | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Leon Patrick | 2 |
#2 | Bristow Michael | 2 |
#3 | Webb Norve | 2 |
#4 | Domet Jack | 2 |
#5 | Gorczynski Richard | 2 |
#6 | Jarosz Paul | 2 |
#7 | Shah Dhiren | 2 |
#8 | Hrib Nicolas | 1 |
#9 | Warshawsky Alan M | 1 |
#10 | Largeau Denis | 1 |
Publication | Filing date | Title |
---|---|---|
AU2004299058A1 | Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure |